Staple oligomers induce a stable RNA G-quadruplex structure for protein translation inhibition in therapeutics

Gene-silencing mechanisms using RNA interference (RNAi) and antisense oligomers have drawn attention to nucleic acid medicines. However, several challenges remain such as low in vivo stability and inadequate target selectivity. Here we report a versatile and highly selective method for suppressing gene expression with a short oligonucleotide. The oligonucleotide, a Staple oligomer, hybridizes specifically to a target mRNA and artificially induces a higher-order structure, an RNA G-quadruplex (rG4), on the mRNA. This results in the rG4 effectively suppressing the target protein's translation. The method is validated by successfully regulating translation of TPM3, MYD88 and TRPC6 mRNAs in a cell-free system and in living mammalian cells. Unlike RNAi and antisense technologies, the present technology does not require cooperation with bioprocesses, permitting the quick and easy development of fully non-natural nucleic acid-based Staple oligomers without compromising their effectiveness. In vivo application of the technology to TRPC6 mRNA helps prevent cardiac hypertrophy in thoracic aortic constriction-treated mice without detectable off-target effects. This technology provides new insights into gene therapy after RNAi and antisense technologies.

Authors

Institutions

Publication Details

Journal
Nature Biomedical Engineering
Published
2025-10-15
DOI
https://doi.org/10.1038/s41551-025-01515-4
Citations
1
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
0.81

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Staple oligomers induce a stable RNA G-quadruplex structure for protein translation inhibition in therapeutics

Masaki Hagihara, Yasunobu Hasegawa, Tomoki Kida, Yousuke Katsuda et al.
1 citations
Nature Biomedical Engineering
RNA Interference and Gene Delivery
0.81
article

Staple oligomers induce a stable RNA G-quadruplex structure for protein translation inhibition in therapeutics

Masaki Hagihara, Yasunobu Hasegawa, Tomoki Kida, Yousuke Katsuda, Shuhei Shiroto, Hiroyuki Asanuma, Kenichi Tsujita, Takuto Kamura, Toshihiro Ihara, Taishi Nakamura, Shin‐ichi Sato, Yuki Sakamoto, R Ohno, Yukiko Kamiya, Yusuke Kitamura, Shinichiro Nakamura, Kozo Utsumi
article en
1 citations

Abstract

Gene-silencing mechanisms using RNA interference (RNAi) and antisense oligomers have drawn attention to nucleic acid medicines. However, several challenges remain such as low in vivo stability and inadequate target selectivity. Here we report a versatile and highly selective method for suppressing gene expression with a short oligonucleotide. The oligonucleotide, a Staple oligomer, hybridizes specifically to a target mRNA and artificially induces a higher-order structure, an RNA G-quadruplex (rG4), on the mRNA. This results in the rG4 effectively suppressing the target protein's translation. The method is validated by successfully regulating translation of TPM3, MYD88 and TRPC6 mRNAs in a cell-free system and in living mammalian cells. Unlike RNAi and antisense technologies, the present technology does not require cooperation with bioprocesses, permitting the quick and easy development of fully non-natural nucleic acid-based Staple oligomers without compromising their effectiveness. In vivo application of the technology to TRPC6 mRNA helps prevent cardiac hypertrophy in thoracic aortic constriction-treated mice without detectable off-target effects. This technology provides new insights into gene therapy after RNAi and antisense technologies.

Nature Biomedical Engineering
Hirosaki University (JP), Kumamoto Health Science University (JP), Kobe Pharmaceutical University (JP), Kyoto University (JP), Kyoto University Institute for Chemical Research, Nagoya University (JP), Kumamoto University (JP), The University of Osaka (JP)
Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science
Openalex Percentile: Top 23%
RNA Interference and Gene Delivery
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.